FABULINUS
Aim is to evaluate frexalimab.
Free · Designed for iPad. Not verified for macOS.
Aims to evaluate frexalimab's effect and their function on the secretion of insulin in participants with recently diagnosed type 1 diabetes.
This application has been created especially for the FABULINUS DRI17476 study participants and will support you through all steps of the study conduct. You will use this app to perform and complete questionnaires, electronic diaries and access study related information.
Ratings & Reviews
- This app hasn’t received enough ratings or reviews to display an overview.
Additional milestones and update to Study injection diary.
The developer, Hello Thread, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Contact Info
- User Content
- Usage Data
- Diagnostics
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- Definitive Media Corp.
- Size
- 139.3 MB
- Category
- Medical
- Compatibility
Requires iOS 15.6 or later.
- iPhone
Requires iOS 15.6 or later. - iPad
Requires iPadOS 15.6 or later. - iPod touch
Requires iOS 15.6 or later. - Mac
Requires macOS 12.5 or later and a Mac with Apple M1 chip or later. - Apple Vision
Requires visionOS 1.0 or later.
- iPhone
- Languages
English and 46 more
- English, Afrikaans, Amharic, Arabic, Belarusian, Bulgarian, Croatian, Czech, Danish, Dutch, Estonian, Finnish, French, Georgian, German, Greek, Gujarati, Hebrew, Hindi, Hungarian, Italian, Japanese, Kannada, Korean, Latvian, Lithuanian, Malay, Malayalam, Norwegian Bokmål, Polish, Portuguese, Romanian, Russian, Serbian, Sesotho, Setswana, Simplified Chinese, Slovak, Slovenian, Spanish, Swedish, Traditional Chinese, Turkish, Ukrainian, Vietnamese, Xhosa, Zulu
- Age Rating
13+
- 13+
- Infrequent
Medical Treatment information
- Copyright
- © 2026 THREAD